Phytonanomedicine as a therapeutic regulator of the tumor microenvironment for inhibiting cancer metastasis
- 29 May 2024
- journal article
- editorial
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (14) , 1227-1229
Abstract
TWEETABLE ABSTRACT “The development of phytonanomedicine-based approach seems to be a very promising candidate for modulating protumorigenic tumor microenvironment to suppress cancer metastasis.”Keywords
This publication has 17 references indexed in Scilit:
- Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological InsightsMolecular Pharmaceutics, 2023
- MetastasisCell, 2023
- Cancer nanomedicine: a review of nano-therapeutics and challenges aheadRSC Advances, 2023
- Advancements in clinical translation of flavonoid nanoparticles for cancer treatmentOpenNano, 2022
- Phytochemical based nanomedicine: a panacea for cancer treatment, present status and future prospectiveOpenNano, 2022
- Targeting metastatic cancerNature Medicine, 2021
- Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical UseInternational Journal of Nanomedicine, 2020
- Phytonanomedicine: a novel avenue to treat recurrent cancer by targeting cancer stem cellsDrug Discovery Today, 2020
- Phytotherapeutics in cancer invasion and metastasisPhytotherapy Research, 2018
- Clinical ManagementThe Cancer Journal, 2017